Interested in the Guggenheim Fellowships?

In this one-hour session, hear from Laura Auricchio, Vice President and Secretary of the Guggenheim Foundation and Dr. Angela Esterhammer, 2025 Guggenheim Fellow as they share perspectives on the application process, what defines excellence across disciplines, and the impact of the fellowship experience.

Date: Thursday, June 18, 2026

Time: 1:00 p.m. - 2:00 p.m. EST

Cost: Free

This event is open to everyone who wants to contribute to creating accessible research environments.

In honour of Quebec’s Week for Persons with Disabilities, D2R - in collaboration with the Quebec Interuniversity Network in Equity, Diversity and Inclusion with and the Equity Team at McGill University - invites you to a Lunch & Learn to present the new Practical Toolkit for Research Teams to foster Accessibility in Research Labs.

During this event we will present a few key elements of this toolkit, including:

At event honouring 116 winners of major awards, keynote speaker and SSHRC Gold Medal recipient Myriam Denov emphasized the importance of listening.

McGill celebrated more than 100 researchers at the 21^st edition of Bravo, a gala event May 7 honouring the winners of major provincial, national and international research prizes and awards in 2025.

From fundamental physics to child well-being, McGill researchers advance discovery across disciplines 

McGill has been awarded $18.1 million in federal funding to support 16 Canada Research Chairs – six new and 10 renewed.

Mallik Mahmud, Assistant Professor in the Department of Geography, is one of nine early-career ocean researchers across Canada awarded the 2026 Early Career Researcher Award by the Marine Environmental Observation Prediction and Response Network (MEOPAR), recognizing exceptional early-career ocean researchers whose work advances climate resilience.

Montreal, May 6, 2026 – Researchers from McGill University have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.

Montreal – April 29, 2026 | McGill University’s DNA to RNA Initiative (D2R) has invested nearly $6 million in funding to support four groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on April 23-24, 2026.